NextCure (NXTC) Net Cash Flow (2018 - 2026)
NextCure (NXTC) posted quarterly Net Cash Flow of -$10.8 million for Q1 2026, down 83.31% year-over-year from -$64.8 million in Q1 2025, and down 157.96% quarter-over-quarter from $18.7 million in Q4 2025.
NextCure (NXTC) Net Cash Flow (2018 - 2026) Analysis & Trends
NextCure's Net Cash Flow history runs 9 years deep, the most recent figure standing at -$10.8 million for Q1 2026.
- In Q1 2026, Net Cash Flow fell 83.31% year-over-year to -$10.8 million; the TTM figure through Mar 2026 stood at -$8.7 million (down 350.19% YoY), while the FY2025 annual figure was -$1.7 million, down 111.92% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$10.8 million, down from $18.7 million in the prior quarter.
- The five-year high for Net Cash Flow was $18.7 million in Q4 2025, with the low at -$19.0 million in Q2 2025.
- The 5-year median for Net Cash Flow is $26000.0 (2024), against an average of $42823.5.
- Peak annual rise in Net Cash Flow reached 71661.54% in 2025, while the deepest fall reached 861.2% in 2025.
- NextCure's Net Cash Flow stood at -$4.4 million in 2022, then tumbled by 45.63% to -$6.4 million in 2023, then surged by 100.4% to $26000.0 in 2024, then soared by 71661.54% to $18.7 million in 2025, then tumbled by 157.96% to -$10.8 million in 2026.
- Business Quant data shows NXTC's Net Cash Flow at -$10.8 million in Q1 2026, $18.7 million in Q4 2025, and $2.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | NextCure | 33.72 Mn | 33.72 Mn | - | 93,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 93,000.00 |
| Jun 30, 2026 | 93,000.00 |
| Mar 31, 2026 | -10.82 Mn |
| Mar 31, 2026 | -10.82 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Dec 31, 2025 | 18.66 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.43 Mn |
| Jun 30, 2025 | -18.95 Mn |
| Jun 30, 2025 | -18.95 Mn |
| Mar 31, 2025 | -5.90 Mn |
| Mar 31, 2025 | -5.90 Mn |
| Dec 31, 2024 | 26,000.00 |
| Dec 31, 2024 | 26,000.00 |
| Sep 30, 2024 | 6.85 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 2.49 Mn |
| Mar 31, 2024 | 5.28 Mn |
| Mar 31, 2024 | 5.28 Mn |